KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Non-Current Assets (2016 - 2025)

Opko Health (OPK) has disclosed Non-Current Assets for 16 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 12.23% year-over-year to $1.4 billion, compared with a TTM value of $5.5 billion through Dec 2025, down 13.67%, and an annual FY2025 reading of $1.4 billion, down 12.23% over the prior year.
  • Non-Current Assets was $1.4 billion for Q4 2025 at Opko Health, down from $1.4 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.9 billion in Q1 2021 and bottomed at $1.4 billion in Q4 2025.
  • Average Non-Current Assets over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
  • The sharpest move saw Non-Current Assets decreased 19.15% in 2022, then grew 13.55% in 2023.
  • Year by year, Non-Current Assets stood at $1.6 billion in 2021, then increased by 12.43% to $1.8 billion in 2022, then decreased by 3.98% to $1.7 billion in 2023, then dropped by 9.64% to $1.5 billion in 2024, then decreased by 12.23% to $1.4 billion in 2025.
  • Business Quant data shows Non-Current Assets for OPK at $1.4 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.4 billion in Q2 2025.